| Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP Y Liu-Chittenden, B Huang, JS Shim, Q Chen, SJ Lee, RA Anders, JO Liu, ... Genes & development 26 (12), 1300-1305, 2012 | 1398 | 2012 |
| Targeting epithelial–mesenchymal transition (EMT) to overcome drug resistance in cancer B Du, JS Shim Molecules 21 (7), 965, 2016 | 731 | 2016 |
| Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs JS Shim, JO Liu International Journal of Biological Sciences 10 (7), 654-663, 2014 | 398 | 2014 |
| Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells SM Choi, Y Kim, JS Shim, JT Park, RH Wang, SD Leach, JO Liu, C Deng, ... Hepatology 57 (6), 2458-2468, 2013 | 273 | 2013 |
| Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth J Lin, MC Haffner, Y Zhang, BH Lee, WN Brennen, J Britton, SK Kachhap, ... The Prostate 71 (4), 333-343, 2011 | 215 | 2011 |
| Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin JS Shim, JH Kim, HY Cho, YN Yum, SH Kim, HJ Park, BS Shim, SH Choi, ... Chemistry & biology 10 (8), 695-704, 2003 | 215 | 2003 |
| A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment EA Platz, S Yegnasubramanian, JO Liu, CR Chong, JS Shim, SA Kenfield, ... Cancer discovery 1 (1), 68-77, 2011 | 194 | 2011 |
| Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation JS Shim, DH Kim, HJ Jung, JH Kim, D Lim, SK Lee, KW Kim, JW Ahn, ... Bioorganic & medicinal chemistry 10 (9), 2987-2992, 2002 | 178 | 2002 |
| A New Curcumin Derivative, HBC, Interferes with the Cell Cycle Progression of Colon Cancer Cells via Antagonization of the Ca2+/Calmodulin Function JS Shim, J Lee, HJ Park, SJ Park, HJ Kwon Chemistry & biology 11 (10), 1455-1463, 2004 | 131 | 2004 |
| Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen … HJ Jung, JS Shim, J Lee, YM Song, KC Park, SH Choi, ND Kim, JH Yoon, ... Journal of Biological Chemistry 285 (15), 11584-11595, 2010 | 129 | 2010 |
| Effect of nitroxoline on angiogenesis and growth of human bladder cancer JS Shim, Y Matsui, S Bhat, BA Nacev, J Xu, HC Bhang, S Dhara, KC Han, ... Journal of the National Cancer Institute 102 (24), 1855-1873, 2010 | 126 | 2010 |
| Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells SA Head, W Shi, L Zhao, K Gorshkov, K Pasunooti, Y Chen, Z Deng, R Li, ... Proceedings of the National Academy of Sciences 112 (52), E7276-E7285, 2015 | 121 | 2015 |
| Betulinic acid inhibits growth factor‐induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells HJ Kwon, JS Shim, JH Kim, HY Cho, YN Yum, SH Kim, J Yu Japanese journal of cancer research 93 (4), 417-425, 2002 | 119 | 2002 |
| Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata JS Shim, JH Kim, J Lee, SN Kim, HJ Kwon Planta medica 70 (02), 171-173, 2004 | 118 | 2004 |
| Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro JS Shim, HS Lee, J Shin, HJ Kwon Cancer letters 203 (2), 163-169, 2004 | 111 | 2004 |
| Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells C Wu, J Lyu, EJ Yang, Y Liu, B Zhang, JS Shim Nature Communications 9 (1), 3212, 2018 | 108 | 2018 |
| Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir JS Shim, R Rao, K Beebe, L Neckers, I Han, R Nahta, JO Liu Journal of the National Cancer Institute 104 (20), 1576-1590, 2012 | 105 | 2012 |
| First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass G Wang, SK Rajpurohit, F Delaspre, SL Walker, DT White, A Ceasrine, ... Elife 4, e08261, 2015 | 99 | 2015 |
| Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation M Rovira, W Huang, S Yusuff, JS Shim, AA Ferrante, JO Liu, MJ Parsons Proceedings of the National Academy of Sciences 108 (48), 19264-19269, 2011 | 99 | 2011 |
| Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro JM Hur, JS Shim, HJ Jung, HJ Kwon Experimental & molecular medicine 37 (2), 133-137, 2005 | 96 | 2005 |
Ruojing LiUS Food and Drug Administration在 fda.hhs.gov 的电子邮件经过验证
